Hong Seng to acquire 51% in RZAC

PETALING JAYA: Hong Seng Consolidated Bhd’s wholly-owned subsidiary, HS Bio Sdn Bhd, has signed a heads of agreement following a proposed acquisition of 51% shareholdings in RZAC Immunesafe Sdn Bhd for RM40.3mil.

In a filing with Bursa Malaysia yesterday, the company said the agreement was signed with Datuk Seri Shahril Mokhtar, Datuk Wan Khalik Wan Muhammad and RZAC Business Sdn Bhd. – Bernama